Artiva Biotherapeutics (ARTV) Other financing activities (2024 - 2025)
Artiva Biotherapeutics (ARTV) posted quarterly Other financing activities of $138000.0 for Q1 2025, up 500.0% quarter-over-quarter from $23000.0 in Q4 2024.
Powered by 
Analysis
Artiva Biotherapeutics (ARTV) Other financing activities (2024 - 2025) Analysis & Trends
Artiva Biotherapeutics (ARTV) has reported Other financing activities for 2 consecutive years, with $138000.0 the latest figure, recorded in Q1 2025.
- In Q1 2025, Other financing activities changed N/A year-over-year to $138000.0; the TTM figure through Dec 2025 stood at $138000.0 (up 375.86% YoY), while the FY2025 annual figure was $138000.0, up 170.59% from the prior year.
- Other financing activities improved to $138000.0 in Q1 2025 per ARTV's latest filing, from $23000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $138000.0 in Q1 2025 and bottomed at $6000.0 in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Artiva Biotherapeutics | 441.23 Mn | 441.23 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 138,000.00 |
| Dec 31, 2024 | 23,000.00 |
| Sep 30, 2024 | 6,000.00 |